Lexicon Pharmaceuticals, Inc. (LXRX)
1.71
+0.07
(+4.27%)
USD |
NASDAQ |
Mar 06, 16:00
1.69
-0.02
(-1.17%)
After-Hours: 20:00
Lexicon Pharmaceuticals EPS Diluted (Quarterly) : -0.0427 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Viemed Healthcare, Inc. | 0.1483 |
| Novavax, Inc. | 0.1061 |
| Kura Oncology, Inc. | -0.9199 |
| Liquidia Corp. | 0.1455 |
| Agenus, Inc. | 1.944 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -15.53M |
| Revenue (Quarterly) | 5.493M |
| Total Expenses (Quarterly) | 21.02M |
| Enterprise Value | 587.42M |
| Gross Profit Margin (Quarterly) | 94.19% |
| Profit Margin (Quarterly) | -282.7% |
| Earnings Yield | -8.12% |
| Normalized Earnings Yield | -8.117 |